News

FSN Capital VI & Prange Group: Accelerating Adragos Pharma Growth

Munich / Plettenberg, 09. August 2021 – FSN Capital VI* (“FSNC”) has acquired a majority share in Adragos Pharma Group (“Adragos”), a growing B2B contract developer and manufacturer (CDMO) for pharmaceuticals. The current owner, Prange Group (“PG”), remains invested to […]

Subscribe to our newsletter!

Get notified on our latest news.